Report Detail
Global Typhoid Vaccine Market Insights, Forecast to 2025
- RnM3234610 |
- 02 April, 2019 |
- Global |
- 117 Pages |
- QYResearch |
- Pharma & Healthcare
The global Typhoid Vaccine market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Typhoid Vaccine market based on company, product type, end user and key regions.
This report studies the global market size of Typhoid Vaccine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Typhoid Vaccine in these regions.
This research report categorizes the global Typhoid Vaccine market by top players/brands, region, type and end user. This report also studies the global Typhoid Vaccine market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Sanofi
Merck
GlaxoSmithKline
PaxVax
Actiza Pharmaceutical
Merit Pharmaceuticals
Bharat Biotec
Market size by Product
Oral Type
Injection Type
Market size by End User
Hospital
Research & Academic Laboratories
Pharmaceutical & Biotechnology Companies
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Typhoid Vaccine market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Typhoid Vaccine market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Typhoid Vaccine companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Typhoid Vaccine submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Typhoid Vaccine are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Typhoid Vaccine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Typhoid Vaccine Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Typhoid Vaccine Market Size Growth Rate by Product
- 1.4.2 Oral Type
- 1.4.3 Injection Type
- 1.5 Market by End User
- 1.5.1 Global Typhoid Vaccine Market Size Growth Rate by End User
- 1.5.2 Hospital
- 1.5.3 Research & Academic Laboratories
- 1.5.4 Pharmaceutical & Biotechnology Companies
- 1.5.5 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Typhoid Vaccine Market Size
- 2.1.1 Global Typhoid Vaccine Revenue 2014-2025
- 2.1.2 Global Typhoid Vaccine Sales 2014-2025
- 2.2 Typhoid Vaccine Growth Rate by Regions
- 2.2.1 Global Typhoid Vaccine Sales by Regions
- 2.2.2 Global Typhoid Vaccine Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Typhoid Vaccine Sales by Manufacturers
- 3.1.1 Typhoid Vaccine Sales by Manufacturers
- 3.1.2 Typhoid Vaccine Sales Market Share by Manufacturers
- 3.1.3 Global Typhoid Vaccine Market Concentration Ratio (CR5 and HHI)
- 3.2 Typhoid Vaccine Revenue by Manufacturers
- 3.2.1 Typhoid Vaccine Revenue by Manufacturers (2014-2019)
- 3.2.2 Typhoid Vaccine Revenue Share by Manufacturers (2014-2019)
- 3.3 Typhoid Vaccine Price by Manufacturers
- 3.4 Typhoid Vaccine Manufacturing Base Distribution, Product Types
- 3.4.1 Typhoid Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Typhoid Vaccine Product Type
- 3.4.3 Date of International Manufacturers Enter into Typhoid Vaccine Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Typhoid Vaccine Sales by Product
- 4.2 Global Typhoid Vaccine Revenue by Product
- 4.3 Typhoid Vaccine Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Typhoid Vaccine Breakdown Data by End User
6 North America
- 6.1 North America Typhoid Vaccine by Countries
- 6.1.1 North America Typhoid Vaccine Sales by Countries
- 6.1.2 North America Typhoid Vaccine Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Typhoid Vaccine by Product
- 6.3 North America Typhoid Vaccine by End User
7 Europe
- 7.1 Europe Typhoid Vaccine by Countries
- 7.1.1 Europe Typhoid Vaccine Sales by Countries
- 7.1.2 Europe Typhoid Vaccine Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Typhoid Vaccine by Product
- 7.3 Europe Typhoid Vaccine by End User
8 Asia Pacific
- 8.1 Asia Pacific Typhoid Vaccine by Countries
- 8.1.1 Asia Pacific Typhoid Vaccine Sales by Countries
- 8.1.2 Asia Pacific Typhoid Vaccine Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Typhoid Vaccine by Product
- 8.3 Asia Pacific Typhoid Vaccine by End User
9 Central & South America
- 9.1 Central & South America Typhoid Vaccine by Countries
- 9.1.1 Central & South America Typhoid Vaccine Sales by Countries
- 9.1.2 Central & South America Typhoid Vaccine Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Typhoid Vaccine by Product
- 9.3 Central & South America Typhoid Vaccine by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Typhoid Vaccine by Countries
- 10.1.1 Middle East and Africa Typhoid Vaccine Sales by Countries
- 10.1.2 Middle East and Africa Typhoid Vaccine Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Typhoid Vaccine by Product
- 10.3 Middle East and Africa Typhoid Vaccine by End User
11 Company Profiles
- 11.1 Sanofi
- 11.1.1 Sanofi Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Sanofi Typhoid Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Sanofi Typhoid Vaccine Products Offered
- 11.1.5 Sanofi Recent Development
- 11.2 Merck
- 11.2.1 Merck Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Merck Typhoid Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Merck Typhoid Vaccine Products Offered
- 11.2.5 Merck Recent Development
- 11.3 GlaxoSmithKline
- 11.3.1 GlaxoSmithKline Company Details
- 11.3.2 Company Business Overview
- 11.3.3 GlaxoSmithKline Typhoid Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 GlaxoSmithKline Typhoid Vaccine Products Offered
- 11.3.5 GlaxoSmithKline Recent Development
- 11.4 PaxVax
- 11.4.1 PaxVax Company Details
- 11.4.2 Company Business Overview
- 11.4.3 PaxVax Typhoid Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 PaxVax Typhoid Vaccine Products Offered
- 11.4.5 PaxVax Recent Development
- 11.5 Actiza Pharmaceutical
- 11.5.1 Actiza Pharmaceutical Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Actiza Pharmaceutical Typhoid Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Actiza Pharmaceutical Typhoid Vaccine Products Offered
- 11.5.5 Actiza Pharmaceutical Recent Development
- 11.6 Merit Pharmaceuticals
- 11.6.1 Merit Pharmaceuticals Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Merit Pharmaceuticals Typhoid Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Merit Pharmaceuticals Typhoid Vaccine Products Offered
- 11.6.5 Merit Pharmaceuticals Recent Development
- 11.7 Bharat Biotec
- 11.7.1 Bharat Biotec Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Bharat Biotec Typhoid Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Bharat Biotec Typhoid Vaccine Products Offered
- 11.7.5 Bharat Biotec Recent Development
12 Future Forecast
- 12.1 Typhoid Vaccine Market Forecast by Regions
- 12.1.1 Global Typhoid Vaccine Sales Forecast by Regions 2019-2025
- 12.1.2 Global Typhoid Vaccine Revenue Forecast by Regions 2019-2025
- 12.2 Typhoid Vaccine Market Forecast by Product
- 12.2.1 Global Typhoid Vaccine Sales Forecast by Product 2019-2025
- 12.2.2 Global Typhoid Vaccine Revenue Forecast by Product 2019-2025
- 12.3 Typhoid Vaccine Market Forecast by End User
- 12.4 North America Typhoid Vaccine Forecast
- 12.5 Europe Typhoid Vaccine Forecast
- 12.6 Asia Pacific Typhoid Vaccine Forecast
- 12.7 Central & South America Typhoid Vaccine Forecast
- 12.8 Middle East and Africa Typhoid Vaccine Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Typhoid Vaccine Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Typhoid Vaccine. Industry analysis & Market Report on Typhoid Vaccine is a syndicated market report, published as Global Typhoid Vaccine Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Typhoid Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
